REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,241,860 | +71.3% | 218,143 | +52.8% | 0.00% | +33.3% |
| Q1 2023 | $12,983,285 | +25.1% | 142,799 | -47.7% | 0.00% | +50.0% |
| Q4 2022 | $10,379,552 | +18.8% | 273,218 | -21.4% | 0.00% | 0.0% |
| Q3 2022 | $8,738,000 | +277.1% | 347,730 | +356.0% | 0.00% | +100.0% |
| Q2 2022 | $2,317,000 | -34.1% | 76,255 | -29.0% | 0.00% | 0.0% |
| Q1 2022 | $3,517,000 | -88.7% | 107,357 | -90.9% | 0.00% | -83.3% |
| Q4 2021 | $31,184,000 | +74.7% | 1,182,570 | +566.6% | 0.01% | +50.0% |
| Q3 2021 | $17,849,000 | +103.8% | 177,409 | +186.7% | 0.00% | +100.0% |
| Q2 2021 | $8,759,000 | -62.1% | 61,884 | -73.3% | 0.00% | -66.7% |
| Q1 2021 | $23,106,000 | -19.9% | 231,751 | -0.6% | 0.01% | -14.3% |
| Q4 2020 | $28,831,000 | -4.4% | 233,224 | -24.7% | 0.01% | -22.2% |
| Q3 2020 | $30,162,000 | -31.1% | 309,610 | +10.4% | 0.01% | -30.8% |
| Q2 2020 | $43,761,000 | +75.8% | 280,489 | +62.7% | 0.01% | +44.4% |
| Q1 2020 | $24,891,000 | -24.8% | 172,442 | +6.4% | 0.01% | +12.5% |
| Q4 2019 | $33,121,000 | +218.6% | 162,018 | +25.1% | 0.01% | +166.7% |
| Q3 2019 | $10,397,000 | +39.2% | 129,497 | +63.6% | 0.00% | +50.0% |
| Q2 2019 | $7,467,000 | +6.0% | 79,134 | -4.0% | 0.00% | 0.0% |
| Q1 2019 | $7,043,000 | +186.9% | 82,403 | +88.3% | 0.00% | +100.0% |
| Q4 2018 | $2,455,000 | +23.2% | 43,771 | +79.5% | 0.00% | 0.0% |
| Q3 2018 | $1,993,000 | +88.2% | 24,381 | -19.5% | 0.00% | – |
| Q2 2018 | $1,059,000 | +75.3% | 30,290 | +2.8% | 0.00% | – |
| Q1 2018 | $604,000 | +96.7% | 29,472 | +171.7% | 0.00% | – |
| Q4 2017 | $307,000 | +36.4% | 10,849 | +27.0% | 0.00% | – |
| Q3 2016 | $225,000 | -79.3% | 8,542 | -84.5% | 0.00% | – |
| Q2 2016 | $1,088,000 | – | 55,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |